StreetInsider

• Log in to your account:

  
  Log in
• Signup
• Home
• EPS Insider
• Event Calendar
• Conferences
• Classic Site

Upgrade to SI Premium - Free Trial

VIVS (VIVS)

VivoSim Labs plans rat liver model to pair with human platform September 1, 2026 8:06 AM - StreetInsider VivoSim Labs to Add Rat Liver Model to NAMkind Platform September 1, 2026 8:05 AM - StreetInsider Form ARS VivoSim Labs, INC. For: Mar 31 August 21, 2026 4:06 PM - SEC Filing Form 8-K VivoSim Labs, INC. For: Aug 17 August 21, 2026 4:06 PM - SEC Filing Form DEF 14A VivoSim Labs, INC. For: Sep 30 August 21, 2026 4:02 PM - SEC Filing Form SCHEDULE 13G/A VivoSim Labs, INC. Filed by: Esousa Group Holdings LLC August 17, 2026 9:00 PM - SEC Filing Form PRER14A VivoSim Labs, INC. August 13, 2026 5:02 PM - SEC Filing Form 10-Q VivoSim Labs, INC. For: Jun 30 August 12, 2026 4:07 PM - SEC Filing Form EFFECT VivoSim Labs, INC. August 11, 2026 6:08 AM - SEC Filing Form PRE 14A VivoSim Labs, INC. For: Sep 30 August 10, 2026 9:01 AM - SEC Filing Form 8-K VivoSim Labs, INC. For: Aug 06 August 6, 2026 8:06 AM - SEC Filing VivoSim Labs regains Nasdaq compliance after cash infusion August 6, 2026 8:05 AM - StreetInsider VivoSim Provides Financial and Listing Compliance Update August 6, 2026 8:05 AM - StreetInsider Form S-1 VivoSim Labs, INC. July 31, 2026 4:16 PM - SEC Filing Form 8-K VivoSim Labs, INC. For: Jul 30 July 30, 2026 4:13 PM - SEC Filing Form 8-K VivoSim Labs, INC. For: Jul 20 July 24, 2026 4:07 PM - SEC Filing VivoSim makes first commercial sales in China for NAMkind testing July 21, 2026 8:05 AM - StreetInsider VivoSim Enters China with First Commercial Sales of NAMkind™ Toxicology Screening and Efficacy Testing Services July 21, 2026 8:05 AM - StreetInsider Form 8-K VivoSim Labs, INC. For: Jul 16 July 17, 2026 8:45 AM - SEC Filing VivoSim Labs prices $4M private placement at $0.85 per share July 16, 2026 8:30 AM - StreetInsider VivoSim Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Healthcare Focused Institutional Investor July 16, 2026 8:30 AM - StreetInsider Three Biotechs Deliver Catalysts to Watch July 15, 2026 10:43 AM - StreetInsider VivoSim receives $5M milestone payment from Eli Lilly July 15, 2026 8:05 AM - StreetInsider VivoSim Receives $5M Milestone Payment from Eli Lilly; Provides Guidance That It Expects Revenue Growth of 500%+ in FY2027 July 15, 2026 8:05 AM - StreetInsider Form 10-K VivoSim Labs, INC. For: Mar 31 July 14, 2026 4:51 PM - SEC Filing Form NT 10-K VivoSim Labs, INC. For: Mar 31 June 29, 2026 4:06 PM - SEC Filing VivoSim presents liver toxicity data at European toxicology conference June 29, 2026 8:05 AM - StreetInsider VivoSim Presents Data Showing Superiority to Competition in NAM Liver Tox Prediction at European Toxicology Meeting June 29, 2026 8:05 AM - StreetInsider Full Article List